{
    "Trade/Device Name(s)": [
        "hCG One Step Pregnancy Test"
    ],
    "Submitter Information": "Healstone Biotech Inc.",
    "510(k) Number": "K212418",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123436"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "May 5, 2022",
    "Summary Letter Received Date": "May 5, 2022",
    "Submission Date": "June 29, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow sandwich immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatographic assay"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for the Healstone Biotech hCG One Step Pregnancy Test, a qualitative lateral flow assay for urine hCG.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for human chorionic gonadotropin hormone in urine to aid in early detection of pregnancy, in some cases as early as five days before the expected period.",
    "fda_folder": "Clinical Chemistry"
}